Tet-pLKO.1-puro-shGFP
(Plasmid
#247239)
-
PurposeshRNA control targeting GFP
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 247239 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backboneTet-pLKO-puro
-
Backbone manufacturerDmitri Wiederschain (Addgene #21915)
-
Vector typeMammalian Expression, Lentiviral
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert namenegtive control shRNA targeting GFP
-
gRNA/shRNA sequenceshRNA targeting GFP
-
SpeciesSynthetic
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site unknown (unknown if destroyed)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
Tet-pLKO.1-puro-shGFP was a gift from Miguel Ramalho-Santos (Addgene plasmid # 247239 ; http://n2t.net/addgene:247239 ; RRID:Addgene_247239) -
For your References section:
CHD1 is a synthetic lethal vulnerability in MYC-driven breast cancer. Cho B, Furlan G, Lin P, Shen M, Mittal K, Mazzanti A, Penn LZ, Ramalho-Santos M. Oncogene. 2026 Apr;45(13):1198-1210. doi: 10.1038/s41388-026-03709-9. Epub 2026 Mar 7. 10.1038/s41388-026-03709-9 PubMed 41795021